Filing Details
- Accession Number:
- 0000899243-20-026691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-01 17:52:17
- Reporting Period:
- 2020-09-29
- Accepted Time:
- 2020-10-01 17:52:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1320350 | Lensar Inc. | LNSR | Biological Products, (No Disgnostic Substances) (2836) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
882104 | Pdl Biopharma, Inc. | 932 Southwood Boulevard Incline Village NV 89451 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-29 | 8,703 | $11.16 | 8,667,397 | No | 4 | P | Direct | |
Common Stock | Disposition | 2020-10-01 | 8,667,397 | $0.00 | 0 | No | 4 | J | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | J | Direct |
Footnotes
- In connection with the separation of the Issuer from the Reporting Person on October 1, 2020, the Reporting Person distributed all of the shares of common stock of the Issuer in the form of a dividend to its stockholders.